Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)
Trial for this rare genetic disease to be conducted by NIH/NIAID in partnership with Corvus ITK inhibition intended to address dysregulation of T cells that causes ALPS and has been shown to be ...
Iredell Free News1d
How trauma and prenatal substance exposure harm children’s development, health
"attachment_98933" align="aligncenter" width="750"] Kimberly Siegrist, a certified pediatric nurse practitioner, speaks ...
Medscape5d
Racial Disparities in Pregnancy-related Drinking Reduction
Conclusion Significant racial differences in pregnancy-related drinking reduction are evident, and may help explain racial disparities in FAS. Results suggest that more targeted efforts are needed ...
WebMD2d
Skin Problems & Treatments Resource Center
Trusted, comprehensive information to help you get on the path to clear skin.
Johns Hopkins Medicine5d
Guillain-Barré Syndrome
It needs immediate hospitalization. It can develop over a few days. Or it may take up to several weeks with the greatest weakness occurring within the first couple of weeks after symptoms appear. GBS ...